Daniel Chan, MD
Orthopaedic Trauma · Ft Lauderdale, FLNPI 1275734766
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $93,917 of the $108,657 with a category attached, or 86.4%. Medical Device Business Services, Inc. accounts for 87.5% of it on its own, with 17 other manufacturers making up the rest.
Across 87 payments — averaging $1248.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$95K
- Synthes GmbH$11K
- Stryker$885
- Johnson & Johnson$519
- Osteoremedies, LLC$243
- Smith+Nephew$170
- plus $976 from 12 others
What the payments were for
- Consulting fees$93,91786%
- Speaking & faculty fees$7,0006%
- Travel & lodging$4,1434%
- Food & beverage$3,5973%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 40 | $95,119 |
| Synthes GmbH | 13 | $10,745 |
| Stryker | 8 | $885 |
| Johnson & Johnson(2 entities) | 9 | $519 |
| Osteoremedies, LLC | 1 | $243 |
| Smith+Nephew | 3 | $170 |
| Arthrex | 1 | $169 |
| Acumed LLC | 1 | $158 |
| Illuminoss Medical, Inc. | 1 | $144 |
| Trice Medical, Inc. | 1 | $138 |
| AbbVie | 1 | $125 |
| Zimmer Biomet | 1 | $110 |
| Bioventus LLC | 2 | $34 |
| Nalu Medical, Inc. | 1 | $26 |
| Alvogen Inc | 1 | $26 |
| Amgen | 1 | $18 |
| Vertex | 1 | $17 |
| Covidien LP | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$108,657 in reported general payments places this provider in the 75th percentile of 65 orthopaedic trauma providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 15 | $8,538 |
| Celecoxib | 89 | $1,409 |
| Ondansetron Hcl | 40 | $339 |
| Oxycodone Hcl | 49 | $305 |
| Gabapentin | 49 | $280 |
| Pregabalin | 14 | $149 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $79 |
| Meloxicam | 20 | $66 |
| Tramadol Hcl | 14 | $56 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic trauma in Ft Lauderdale
- Edward PerezFt Lauderdale$981K
- J Dean ColeOrlando$4.2M
- Vuong NguyenOrlando$1.4M
- Hassan MirTemple Terrace$877K
- Daniel SeginaMelbourne$330K
- Kenneth KovalOrlando$321K
- Mohamed ShaathOrlando$303K
- Daniel DziadoszSt Petersburg$262K
- Frank AviluceaOrlando$191K
- Christiaan MamczakSt Petersburg$182K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.